Review



yth n 6 methyladenosine rna binding protein 2  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Proteintech yth n 6 methyladenosine rna binding protein 2
    Yth N 6 Methyladenosine Rna Binding Protein 2, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 516 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yth n 6 methyladenosine rna binding protein 2/product/Proteintech
    Average 98 stars, based on 516 article reviews
    yth n 6 methyladenosine rna binding protein 2 - by Bioz Stars, 2026-02
    98/100 stars

    Images



    Similar Products

    98
    Proteintech yth n 6 methyladenosine rna binding protein 2
    Yth N 6 Methyladenosine Rna Binding Protein 2, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yth n 6 methyladenosine rna binding protein 2/product/Proteintech
    Average 98 stars, based on 1 article reviews
    yth n 6 methyladenosine rna binding protein 2 - by Bioz Stars, 2026-02
    98/100 stars
      Buy from Supplier

    98
    Proteintech yth n 6 methyladenosine rna binding protein 2 ythdf2
    FTO increases the stability of HBEGF mRNA via <t>YTHDF2.</t> (A) Venn diagram showing 135 common genes among three times of repetition from MS results. (B) RIP‐qPCR verified the enrichment of HBEGF mRNA on YTHDF2 protein in MKN45 cells. (C) RNA pull‐down showing the binding of HBEGF mRNA to YTHDF2. (D) Western blotting showed an upregulated protein level of HBEGF with YTHDF2 knockdown in MKN45 cells. (E‐G) qRT‐PCR analysis of HBEGF mRNA in the indicated group when MKN45 cells were exposed to actinomycin D, with or without YTHDF2 knockdown (E), with or without FTO knockdown (F) and with or without FTO overexpression (G). (H) Expression correlation between HBEGF and YTHDF2 levels in GC tissues from the TCGA‐STAD cohort ( n = 408). (I) Log‐rank test indicating the OS of individuals with high ( n = 257) or low ( n = 618) YTHDF2 expression in the GSE62254 . (J) Western blotting showed protein level of HBEGF in MKN45 cells with FTO knockdown or YTHDF2 knockdown. (K) Schematic showing the construction of Flag‐tagged wild‐type or m 6 A modification site‐mutant HBEGF probes. (L‐N) Western blotting showed protein level of Flag‐tagged HBEGF in MKN45 cells among indicated groups, with or without FTO knockdown (L), with or without FTO overexpression (M) and with or without YTHDF2 knockdown (N). ∗ P < 0.05 and ∗∗∗ P < 0.001 according to the unpaired t ‐test (B), two‐way ANOVA (E to G), Pearson correlation tests (H) and log‐rank test (I). Abbreviations: 3’UTR, 3’untranslation region; 5’UTR, 5’untranslation region; CDS, Coding DNA Sequence; Flag‐mut, Flag‐labeled mutant HBEGF ; Flag‐WT, Flag‐labeled wild‐type HBEGF ; FTO mut , mutant FTO ; FTO , fat mass and obesity‐associated protein; GAPDH, Glyceraldehyde 3‐phosphate dehydrogenase; HBEGF , heparin‐binding EGF like growth factor; MS, mass spectrometry; NC , negative control; YTHDF2, YTH N(6)‐methyladenosine RNA binding protein 2.
    Yth N 6 Methyladenosine Rna Binding Protein 2 Ythdf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yth n 6 methyladenosine rna binding protein 2 ythdf2/product/Proteintech
    Average 98 stars, based on 1 article reviews
    yth n 6 methyladenosine rna binding protein 2 ythdf2 - by Bioz Stars, 2026-02
    98/100 stars
      Buy from Supplier

    Image Search Results


    FTO increases the stability of HBEGF mRNA via YTHDF2. (A) Venn diagram showing 135 common genes among three times of repetition from MS results. (B) RIP‐qPCR verified the enrichment of HBEGF mRNA on YTHDF2 protein in MKN45 cells. (C) RNA pull‐down showing the binding of HBEGF mRNA to YTHDF2. (D) Western blotting showed an upregulated protein level of HBEGF with YTHDF2 knockdown in MKN45 cells. (E‐G) qRT‐PCR analysis of HBEGF mRNA in the indicated group when MKN45 cells were exposed to actinomycin D, with or without YTHDF2 knockdown (E), with or without FTO knockdown (F) and with or without FTO overexpression (G). (H) Expression correlation between HBEGF and YTHDF2 levels in GC tissues from the TCGA‐STAD cohort ( n = 408). (I) Log‐rank test indicating the OS of individuals with high ( n = 257) or low ( n = 618) YTHDF2 expression in the GSE62254 . (J) Western blotting showed protein level of HBEGF in MKN45 cells with FTO knockdown or YTHDF2 knockdown. (K) Schematic showing the construction of Flag‐tagged wild‐type or m 6 A modification site‐mutant HBEGF probes. (L‐N) Western blotting showed protein level of Flag‐tagged HBEGF in MKN45 cells among indicated groups, with or without FTO knockdown (L), with or without FTO overexpression (M) and with or without YTHDF2 knockdown (N). ∗ P < 0.05 and ∗∗∗ P < 0.001 according to the unpaired t ‐test (B), two‐way ANOVA (E to G), Pearson correlation tests (H) and log‐rank test (I). Abbreviations: 3’UTR, 3’untranslation region; 5’UTR, 5’untranslation region; CDS, Coding DNA Sequence; Flag‐mut, Flag‐labeled mutant HBEGF ; Flag‐WT, Flag‐labeled wild‐type HBEGF ; FTO mut , mutant FTO ; FTO , fat mass and obesity‐associated protein; GAPDH, Glyceraldehyde 3‐phosphate dehydrogenase; HBEGF , heparin‐binding EGF like growth factor; MS, mass spectrometry; NC , negative control; YTHDF2, YTH N(6)‐methyladenosine RNA binding protein 2.

    Journal: Cancer Communications

    Article Title: Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit‐and‐run” paradigm

    doi: 10.1002/cac2.70004

    Figure Lengend Snippet: FTO increases the stability of HBEGF mRNA via YTHDF2. (A) Venn diagram showing 135 common genes among three times of repetition from MS results. (B) RIP‐qPCR verified the enrichment of HBEGF mRNA on YTHDF2 protein in MKN45 cells. (C) RNA pull‐down showing the binding of HBEGF mRNA to YTHDF2. (D) Western blotting showed an upregulated protein level of HBEGF with YTHDF2 knockdown in MKN45 cells. (E‐G) qRT‐PCR analysis of HBEGF mRNA in the indicated group when MKN45 cells were exposed to actinomycin D, with or without YTHDF2 knockdown (E), with or without FTO knockdown (F) and with or without FTO overexpression (G). (H) Expression correlation between HBEGF and YTHDF2 levels in GC tissues from the TCGA‐STAD cohort ( n = 408). (I) Log‐rank test indicating the OS of individuals with high ( n = 257) or low ( n = 618) YTHDF2 expression in the GSE62254 . (J) Western blotting showed protein level of HBEGF in MKN45 cells with FTO knockdown or YTHDF2 knockdown. (K) Schematic showing the construction of Flag‐tagged wild‐type or m 6 A modification site‐mutant HBEGF probes. (L‐N) Western blotting showed protein level of Flag‐tagged HBEGF in MKN45 cells among indicated groups, with or without FTO knockdown (L), with or without FTO overexpression (M) and with or without YTHDF2 knockdown (N). ∗ P < 0.05 and ∗∗∗ P < 0.001 according to the unpaired t ‐test (B), two‐way ANOVA (E to G), Pearson correlation tests (H) and log‐rank test (I). Abbreviations: 3’UTR, 3’untranslation region; 5’UTR, 5’untranslation region; CDS, Coding DNA Sequence; Flag‐mut, Flag‐labeled mutant HBEGF ; Flag‐WT, Flag‐labeled wild‐type HBEGF ; FTO mut , mutant FTO ; FTO , fat mass and obesity‐associated protein; GAPDH, Glyceraldehyde 3‐phosphate dehydrogenase; HBEGF , heparin‐binding EGF like growth factor; MS, mass spectrometry; NC , negative control; YTHDF2, YTH N(6)‐methyladenosine RNA binding protein 2.

    Article Snippet: Briefly, the cell lysates were incubated at 4°C overnight with A/G magnetic beads (Millipore) in the presence of either an IgG control antibody or a YTH N(6)‐methyladenosine RNA binding protein 2 (YTHDF2) (#24744‐1‐AP, Proteintech, Chicago, IL, USA) antibody.

    Techniques: Binding Assay, Western Blot, Knockdown, Quantitative RT-PCR, Over Expression, Expressing, Modification, Mutagenesis, Sequencing, Labeling, Mass Spectrometry, Negative Control, RNA Binding Assay

    Graph illustration. CagA‐positive H. pylori increases FTO expression, which results in “hit‐and‐run” GC progression. However, the synergism of the FTO inhibitor MA with H. pylori eradication prevents GC development. Abbreviations: CagA, cytotoxin‐associated gene A; CEA, carcinoembryonic antigen; CK20, cytokeratin 20; CK7, cytokeratin 7; EpCAM, epithelial cell adhesion molecule; FTO, fat mass and obesity‐associated protein; FTO, fat mass and obesity‐associated protein; GAPDH, Glyceraldehyde 3‐phosphate dehydrogenase; HBEGF, heparin‐binding EGF like growth factor; JUN, Jun Proto‐Oncogene; m 6 A, N6‐methyladenosine; MA, meclofenamic acid; T4SS, the type IV secretion system; YTHDF2, YTH N(6)‐methyladenosine RNA binding protein 2.

    Journal: Cancer Communications

    Article Title: Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit‐and‐run” paradigm

    doi: 10.1002/cac2.70004

    Figure Lengend Snippet: Graph illustration. CagA‐positive H. pylori increases FTO expression, which results in “hit‐and‐run” GC progression. However, the synergism of the FTO inhibitor MA with H. pylori eradication prevents GC development. Abbreviations: CagA, cytotoxin‐associated gene A; CEA, carcinoembryonic antigen; CK20, cytokeratin 20; CK7, cytokeratin 7; EpCAM, epithelial cell adhesion molecule; FTO, fat mass and obesity‐associated protein; FTO, fat mass and obesity‐associated protein; GAPDH, Glyceraldehyde 3‐phosphate dehydrogenase; HBEGF, heparin‐binding EGF like growth factor; JUN, Jun Proto‐Oncogene; m 6 A, N6‐methyladenosine; MA, meclofenamic acid; T4SS, the type IV secretion system; YTHDF2, YTH N(6)‐methyladenosine RNA binding protein 2.

    Article Snippet: Briefly, the cell lysates were incubated at 4°C overnight with A/G magnetic beads (Millipore) in the presence of either an IgG control antibody or a YTH N(6)‐methyladenosine RNA binding protein 2 (YTHDF2) (#24744‐1‐AP, Proteintech, Chicago, IL, USA) antibody.

    Techniques: Expressing, Binding Assay, RNA Binding Assay